A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells - Wikidata - awgldk - TriplyDB

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

http://www.wikidata.org/entity/Q34972581

about

Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog Nonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS data Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer Oncogenesis and induced pluripotency - commonalities of signalling pathways Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines The converging roles of BRD4 and gene transcription in pluripotency and oncogenesis Overcoming drug resistance and treating advanced prostate cancer Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy.The emerging roles of Oct4 in tumor-initiating cells.Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages.PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3β activation in NCCIT cells.OCT4 mutations in human erythroleukemic cells: implications for multiple drug resistance (MDR) phenotype.Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer.Prognostication of OCT4 isoform expression in prostate cancer.Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming.Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.Emerging stem cell therapies: treatment, safety, and biology.SENP1 regulates PTEN stability to dictate prostate cancer development.Constructing a Mouse Oct4 Promoter/EGFP Vector, as a Whole-Cellular Reporter to Monitor the Pluripotent State of Cells.Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.Application of induced pluripotency in cancer studies.Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells.[Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma].

P2860

Q26797063-6A114B07-4479-4785-B58C-95EFF08DC89F Q28396049-E7928C68-5174-4342-9969-BFC70A8DC876 Q28487410-D139E261-FBFF-4159-A735-1BE93C5815E4 Q31130933-3198C1E2-85ED-451B-9AB7-22E45CB153FF Q34000656-67E47A38-C562-4B75-A4E8-82AC40E76F16 Q34265065-B6E1E73E-4FB6-4A96-95DC-83D53DCB6161 Q35066337-DC83C277-6EA9-4A3D-8B01-5752470EC4B5 Q35476018-E7BA3228-093A-4B3B-B9D0-79DCBA1E1FAF Q35943145-C546D7BB-E878-47DE-A64D-696A81B189C5 Q36081650-5ED75D1F-A725-46CD-BF7E-D6A3B5FA1E1F Q36328812-BB7028FC-B7CA-493D-8AC0-4978EC7ADA56 Q36394044-02431E86-FE62-4EEE-BB6C-D6CE7C3C79D5 Q36435015-42092691-2C73-4A78-A48F-EBAB36F25A91 Q36498067-518EA314-F424-455D-BCD1-1A2A10328A31 Q36507476-8620A59C-7F54-4634-932A-4F832FCBA1A0 Q36910062-0D58B774-BE8D-4A36-B174-5CD02B14A440 Q37548863-9E637F21-8AA8-4DF8-9900-A567FEAE1E90 Q38205189-7722ED1B-D5BE-4B3B-8E0E-E1C8428F82DC Q38719202-65B2F390-2109-4648-913E-CEE93A029C59 Q38893887-8C8B7AFB-E1D8-4D10-AE79-6E439F947C4B Q38901811-73DC5B7C-ACBD-4460-B1EF-3AE305207E44 Q38944007-36E364A6-F516-4A83-9891-A6382F95636A Q38953085-C9FACF0B-FB28-4026-A025-68972644157E Q39121144-68865A46-AE54-4184-B228-B3EFE0A853FB Q39157588-0C472B47-C915-4416-86EA-AE6AE6F88ABF Q39163778-F3F3E4B8-D477-461D-8753-79599355C97A Q39410915-66100FAE-0893-4839-B44D-05FCD50FDD59 Q41955327-97EC23CF-E173-40E1-B815-AE76F8FB94F0 Q42109613-7737F4A5-D0F7-4401-8EF9-BAE6E62ACFC5 Q42146269-C49D18E6-CCA3-4036-90E1-9184CA9CA8FC Q43092220-5F505B9C-F5DF-4BEF-B2BD-DF00CB03C9B3 Q47101770-04589192-2AFB-414C-8E24-AB2BDD4CA630 Q53682453-B8B957A0-D590-4962-BF52-6212BCCB6622 Q55296648-A24205B7-F49A-4DD3-A0E1-F6CB24ED1CFB Q55465382-C3625146-212D-4B29-9156-42DB455C69B1

P2860

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

http://www.wikidata.org/entity/Q34972581

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@ast

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@en

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@nl

type

label

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@ast

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@en

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@nl

prefLabel

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@ast

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@en

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@nl

P1433

Q34972581-3065262A-742B-4441-856C-EFBE7980B2DD

P1476

Q34972581-76B6CABD-C31A-4828-867C-F2F5961E8B98

P2093

Q34972581-00AE53CB-4285-489D-9349-36997F200287

Q34972581-02649C13-B929-4074-93C0-F8CD4F6F1B46

Q34972581-2F44E2DF-8B8C-4BBB-897C-548DA7AE26CF

Q34972581-35C412C6-7B7A-405D-BA74-2C71F53A9DD1

Q34972581-478F8731-207F-4A6C-ABCF-26185C5E99A5

Q34972581-5EF7DB83-9FAF-425E-B862-80BCB967E12A

Q34972581-7728F069-07F5-4808-9B0E-2BD516569884

Q34972581-7BC76594-4330-445A-88CE-3E39BD9909BF

Q34972581-E15D0FBA-E860-409D-96E6-4A8B7ECF35FD

Q34972581-EE9BA947-74FA-4C84-BA62-5294FDC48D41

P2860

Q34972581-00E09362-EF14-499D-9029-B54234A3E9D4

Q34972581-01346CA8-77D8-4503-891D-2095CCD3401F

Q34972581-13960ABA-BAAD-4474-B37A-720A02C1187B

Q34972581-160A2965-4637-44BE-BEA7-F82360E14EB4

Q34972581-1DB77B53-3DCE-43C0-BB48-A35EDA9050D5

Q34972581-21C985D5-CA8B-4178-94CD-3C492D2EF8B2

Q34972581-2E0DCCEC-351C-4467-ABDC-E6219A16379B

Q34972581-33F93D71-47A7-4DBA-BE87-B3D565184292

Q34972581-3788BFEE-2E4B-4511-9105-130D67990021

Q34972581-4897EC15-B476-4721-B07F-74EE9495CFB5

P304

Q34972581-FA956754-2C12-4F25-A4DA-C6F4DF00114A

P31

Q34972581-E022D856-E4C6-45FF-ACBA-599AE2652DB5

P356

Q34972581-FFF87B6F-566E-4780-988D-48544BB6566A

P433

Q34972581-6D7302BC-F982-4DED-BC97-B6341B555CB6

P478

Q34972581-448B7638-DD3A-4877-89AA-61E6A20A9A56

P577

Q34972581-BBB96C49-9492-4ED7-B3EB-8E46DDCA2F01

P5875

Q34972581-738692A9-2788-4A1B-BB73-4358B931F951

P698

Q34972581-65586DA6-C194-4AE2-BC3A-610690AEEB2F

P932

Q34972581-6727D4C7-5D8B-455A-B0A0-7F5F22FC1292

P356

1947601910388271

P1433

P1476

A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

@en

P2093

Angelika M Burger

http://www.w3.org/2001/XMLSchema#string

Douglas E Linn

http://www.w3.org/2001/XMLSchema#string

Feng Sun

http://www.w3.org/2001/XMLSchema#string

Hegang Chen

http://www.w3.org/2001/XMLSchema#string

Hege Chen

http://www.w3.org/2001/XMLSchema#string

Richeng Jiang

http://www.w3.org/2001/XMLSchema#string

Saranya Chumsri

http://www.w3.org/2001/XMLSchema#string

Xi Yang

http://www.w3.org/2001/XMLSchema#string

Yingqiu Xie

http://www.w3.org/2001/XMLSchema#string

Yun Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination

Core transcriptional regulatory circuitry in human embryonic stem cells

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Reprogramming towards pluripotency requires AID-dependent DNA demethylation

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel

The development of androgen-independent prostate cancer

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

P304

908-916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1947601910388271

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51511901

http://www.w3.org/2001/XMLSchema#string

P698

21779471

http://www.w3.org/2001/XMLSchema#string

P932

3092260

http://www.w3.org/2001/XMLSchema#string